BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Osavampator readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Osavampator\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06786624-810@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Osavampator: Phase 3 readout est. (NCT06786624)
DESCRIPTION:Osavampator\, phase 3\, Major Depressive Disorder.\nStudy: Stud
 y to Assess the Efficacy and Safety of Osavampator as an Adjunctive Treatm
 ent in Participants With Major Depressive Disorder (MDD)\nEstimated primar
 y completion: July 2027. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/osavampator#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT06786624
URL:https://assetmemo.bio/drug/osavampator#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06911112-810@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Osavampator: Phase 3 readout est. (NCT06911112)
DESCRIPTION:Osavampator\, phase 3\, Major Depressive Disorder.\nStudy: NBI-
 1065845-MDD3025: Study to Assess the Efficacy and Safety of Osavampator as
  an Adjunctive Treatment in Participants With Major Depressive Disorder (M
 DD)\nEstimated primary completion: July 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/osavampator#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06911112
URL:https://assetmemo.bio/drug/osavampator#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06963021-810@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20270731
DTEND;VALUE=DATE:20270801
SUMMARY:Osavampator: Phase 3 readout est. (NCT06963021)
DESCRIPTION:Osavampator\, phase 3\, Major Depressive Disorder.\nStudy: NBI-
 1065845-MDD3026: Study to Assess the Efficacy and Safety of Osavampator as
  an Adjunctive Treatment in Participants With Major Depressive Disorder (M
 DD)\nEstimated primary completion: July 2027. This is a ClinicalTrials.gov
  estimate\, not a confirmed readout date\, and it can move.\nDrug page: ht
 tps://assetmemo.bio/drug/osavampator#upcoming-events\nRegistry record: htt
 ps://clinicaltrials.gov/study/NCT06963021
URL:https://assetmemo.bio/drug/osavampator#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07196501-810@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20280731
DTEND;VALUE=DATE:20280801
SUMMARY:Osavampator: Phase 3 readout est. (NCT07196501)
DESCRIPTION:Osavampator\, phase 3\, Major Depressive Disorder.\nStudy: A St
 udy to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Tre
 atment in Participants With Major Depressive Disorder (MDD)\nEstimated pri
 mary completion: July 2028. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/osavampator#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT07196501
URL:https://assetmemo.bio/drug/osavampator#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06966401-810@assetmemo.bio
DTSTAMP:20261121T004032Z
DTSTART;VALUE=DATE:20290531
DTEND;VALUE=DATE:20290601
SUMMARY:Osavampator: Phase 3 readout est. (NCT06966401)
DESCRIPTION:Osavampator\, phase 3\, Major Depressive Disorder.\nStudy: Long
 -Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adj
 unctive Treatment in Participants With Major Depressive Disorder (MDD)\nEs
 timated primary completion: May 2029. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/osavampator#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT06966401
URL:https://assetmemo.bio/drug/osavampator#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
